Alteral Therapeutics ApS: Financial statements 2024
CVR: 43730967
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Alteral Therapeutics ApS (CVR 43730967) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK 20,137 compared with DKK 294,398 the year before. Equity in the 2024 report amounted to DKK 354,534. The solvency ratio was 88%.
- Profit/Loss
- DKK 20,137
- Equity
- DKK 354,534
- Total Assets
- DKK 403,017
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Alteral Therapeutics ApS has published its annual report for 2023. The net result was DKK 294,398.
About Alteral Therapeutics ApS
Alteral Therapeutics ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Traugott Wehnert. The company is owned by Wehnert Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -125,267 and a net result of DKK 624,026 compared with DKK 20,137 the year before. Equity in the 2025 report amounted to DKK 978,560.